Browse > Article
http://dx.doi.org/10.3348/kjr.2010.11.3.304

Quantitative Assessment of the T2 Relaxation Time of the Gluteus Muscles in Children with Duchenne Muscular Dystrophy: a Comparative Study Before and After Steroid Treatment  

Kim, Hee-Kyung (Department of Radiology, Cincinnati Children's Hospital Medical Center)
Laor, Tal (Department of Radiology, Cincinnati Children's Hospital Medical Center)
Horn, Paul S. (Department of Mathematical Sciences, University of Cincinnati)
Wong, Brenda (Department of Neurology, Cincinnati Children's Hospital Medical Center)
Publication Information
Korean Journal of Radiology / v.11, no.3, 2010 , pp. 304-311 More about this Journal
Abstract
Objective: To determine the feasibility of using T2 mapping as a quantitative method to longitudinally follow the disease activity in children with Duchenne muscular dystrophy (DMD) who are treated with steroids. Materials and Methods: Eleven boys with DMD (age range: 5-14 years) underwent evaluation with the clinical functional score (CFS), and conventional pelvic MRI and T2 mapping before and during steroid therapy. The gluteus muscle inflammation and fatty infiltration were evaluated on conventional MRI. The histograms and mean T2 relaxation times were obtained from the T2 maps. The CFS, the conventional MRI findings and the T2 values were compared before and during steroid therapy. Results: None of the patients showed interval change of their CFSs. On conventional MRI, none of the images showed muscle inflammation. During steroid treatment, two boys showed increased fatty infiltration on conventional MRI, and both had an increase of the mean T2 relaxation time (p < 0.05). The remaining nine boys had no increase in fatty infiltration. Of these, three showed an increased mean T2 relaxation time (p < 0.05), two showed no change and four showed a decreased mean T2 relaxation time (p < 0.05). Conclusion: T2 mapping is a feasible technique to evaluate the longitudinal muscle changes in those children who receive steroid therapy for DMD. The differences of the mean T2 relaxation time may reflect alterations in disease activity, and even when the conventional MRI and CFS remain stable.
Keywords
Magnetic resonance (MR); Duchenne muscular dystrophy (DMD); Muscle; T2 relaxation time map;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Kight AC, Dardzinski BJ, Laor T, Graham TB. Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage. Arthritis Rheum 2004;50:901-905   DOI   ScienceOn
2 Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007;25:433-440
3 DeSilva S, Drachman DB, Mellits D, Kuncl RW. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol 1987;44:818-822   DOI   ScienceOn
4 Sarnat HB. Neuromuscular disorder. In: Kliegman R, ed. Nelson textbook of pediatrics. Philadelphia: Saunders, 2007:1680-1696
5 Chen YW, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 2005;65:826-834   DOI   ScienceOn
6 Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103   DOI   ScienceOn
7 Liu GC, Jong YJ, Chiang CH, Jaw TS. Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 1993;186:475-480   DOI
8 Kissel JT, Burrow KL, Rammohan KW, Mendell JR. Mononuclear cell analysis of muscle biopsies in prednisonetreated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology 1991;41:667-672   DOI
9 Stern LM, Caudrey DJ, Perrett LV, Boldt DW. Progression of muscular dystrophy assessed by computed tomography. Dev Med Child Neurol 1984;26:569-573
10 Dunn TC, Lu Y, Jin H, Ries MD, Majumdar S. T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology 2004;232:592-598   DOI   ScienceOn
11 Muntoni F, Fisher I, Morgan JE, Abraham D. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord 2002;12:S162-S165   DOI   ScienceOn
12 Davies KE. Challenges in Duchenne muscular dystrophy. Neuromuscul Disord 1997;7:482-486   DOI   ScienceOn
13 Weller B, Massa R, Karpati G, Carpenter S. Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 1991;14:771-774   DOI   ScienceOn
14 Patten C, Meyer RA, Fleckenstein JL. T2 mapping of muscle. Semin Musculoskelet Radiol 2003;7:297-305   DOI   ScienceOn
15 Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 1994;4:59-64   DOI   ScienceOn
16 Bonifati DM, Witchel SF, Ermani M, Hoffman EP, Angelini C, Pegoraro E. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy. J Neurol Neurosurg Psychiatry 2006;77:1177-1179   DOI   ScienceOn
17 Sookhoo S, Mackinnon I, Bushby K, Chinnery PF, Birchall D. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol 2007;62:160-165   DOI   ScienceOn
18 Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, et al. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology 1991;41:661-666   DOI
19 Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004;43:603-608   DOI
20 Strober JB. Therapeutics in duchenne muscular dystrophy. NeuroRx 2006;3:225-234   DOI   ScienceOn
21 Swinyard CA, Deaver GG, Greenspan L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil 1957;38:574-579
22 Phoenix J, Betal D, Roberts N, Helliwell TR, Edwards RH. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996;19:302-310   DOI   ScienceOn